Relmada Therapeutics
RLMD
RLMD
43 hedge funds and large institutions have $319M invested in Relmada Therapeutics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.95%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
11
Increased
18
Reduced
7
Closed
9
Calls
$880K
Puts
$3K
Net Calls
+$877K
Net Calls Change
-$1.25M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
$39.2M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$47.1M |
| 3 |
BlackRock
New York
|
$16.3M |
| 4 |
RI
RTW Investments
New York
|
$33.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$10.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PCM
51
Prelude Capital Management
New York
| – | -$5K | -121 | Closed |
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -36 | Closed |
|